Clinical Services

Our Jack O'Neill Amyloidosis Laboratory provides diagnostic services, including DNA analysis of genes associated with hereditary amyloidosis and systemic autoinflammatory syndromes, and more.

Histology and Proteomic Analysis
Microscope under blue light

Histology and Proteomic Analysis

Accurately identifying the amyloid fibril protein is the vital first step for diagnosis of any amyloidosis patient. Our Jack O’Neill Laboratory performs Congo red staining to confirm amyloid deposits.

Molecular Genetic Testing
DNA helix, in shades of blue and purple

Molecular Genetic Testing

The NAC is the world's largest and the only centre in the UK specialising in diagnosis, research, and management of amyloidosis and hereditary systemic autoinflammatory diseases (SAIDs).

Research and Trials
Proteomics Research Core Facility 800x500

Research and Trials

The aim of all clinical studies is to increase medical knowledge by performing research in human volunteer participants. Discover more about observational studies and clinical trials.

The Amyloidosis Team 2020 in an office
In 2020, the Jack O’Neill Laboratory became the first UK laboratory to receive U
UK Amyloid Proteomics Facility
The Amyloidosis Team outside in medical scrubs, waving

UK Amyloid Proteomics Facility

We routinely use mass spectrometry-based proteomics, both for clinical diagnostics and for research. UK Amyloid Proteomics (UKAMPRO) is the UK’s only UKAS-accredited clinical proteomics facility.